-
Články
- Časopisy
- Kurzy
- Témy
- Kongresy
- Videa
- Podcasty
Establishment of HSV1 Latency in Immunodeficient Mice Facilitates Efficient Reactivation
Although mouse models have been very useful in studies of HSV1 latency, the inability to efficiently reactivate latent HSV1 in vivo has impeded studies of reactivation. Reasoning that reactivation would be much more efficient in the absence of T cells, we exploited IVIG to promote survival of latently infected Rag mice lacking B and T cells. We established a threshold inoculum dose that was higher for B6 - compared to 129-Rag mice, which determined whether HSV1 could be efficiently reactivated in vivo resulting in encephalitis. We showed directly that memory T cells are required to control spontaneous and induced reactivation in mice inoculated at high dose but are dispensable for maintaining latency in low dose inoculated mice. Incorporating different knockout strains into the Rag latency model by adoptive transfer of cells or crossbreeding will facilitate studying the role of various cellular genes involved in regulating neuronal gene expression and innate and adaptive immunity in the control of HSV1 reactivation. The potential of this powerful latency model to unravel the molecular and immune mechanisms regulating latency will be realized only after it is adopted and refined by researchers in the field.
Vyšlo v časopise: Establishment of HSV1 Latency in Immunodeficient Mice Facilitates Efficient Reactivation. PLoS Pathog 11(3): e32767. doi:10.1371/journal.ppat.1004730
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1004730Souhrn
Although mouse models have been very useful in studies of HSV1 latency, the inability to efficiently reactivate latent HSV1 in vivo has impeded studies of reactivation. Reasoning that reactivation would be much more efficient in the absence of T cells, we exploited IVIG to promote survival of latently infected Rag mice lacking B and T cells. We established a threshold inoculum dose that was higher for B6 - compared to 129-Rag mice, which determined whether HSV1 could be efficiently reactivated in vivo resulting in encephalitis. We showed directly that memory T cells are required to control spontaneous and induced reactivation in mice inoculated at high dose but are dispensable for maintaining latency in low dose inoculated mice. Incorporating different knockout strains into the Rag latency model by adoptive transfer of cells or crossbreeding will facilitate studying the role of various cellular genes involved in regulating neuronal gene expression and innate and adaptive immunity in the control of HSV1 reactivation. The potential of this powerful latency model to unravel the molecular and immune mechanisms regulating latency will be realized only after it is adopted and refined by researchers in the field.
Zdroje
1. Yao H-W, Ling P, Chen S-H, Tung Y-Y, Chen S-H. Factors affecting herpes simplex virus reactivation from the explanted mouse brain. Virology 2012; 433 : 116–123. doi: 10.1016/j.virol.2012.07.018 22884293
2. Nicoll MP, Proença JT, Efstathiou S The molecular basis of herpes simplex virus latency. FEMS Microbiology Reviews 2012; 36 : 684–705. doi: 10.1111/j.1574-6976.2011.00320.x 22150699
3. Ramakrishna C, Openshaw H, Cantin EM. The case for immunomodulatory approaches in treating HSV encephalitis. Future Virology 2013; 8 : 259–272. 23956785
4. Whitley RJ. Herpes simplex encephalitis: Adolescents and adults. Antiviral Research 2006; 71 : 141–148. 16675036
5. Tyler KL. Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret's. Herpes 2004; 11 Suppl 2 : 57A–64A. 15319091
6. Bernstein DI, Bellamy AR, Hook EW, Levin MJ, Wald A, et al. Epidemiology, Clinical Presentation, and Antibody Response to Primary Infection With Herpes Simplex Virus Type 1 and Type 2 in Young Women. Clinical Infectious Diseases 2013; 56 : 344–351. doi: 10.1093/cid/cis891 23087395
7. Fatahzadeh M, Schwartz RA. Human herpes simplex virus infections: Epidemiology, pathogenesis, symptomatology, diagnosis, and management. Journal of the American Academy of Dermatology 2007; 57 : 737–763. 17939933
8. Azwa A, Barton SE. Aspects of herpes simplex virus: a clinical review. J Fam Plann Reprod Health Care 2009; 35 : 237–242. doi: 10.1783/147118909789587376 19849918
9. Stranska R, Schuurman R, Nienhuis E, Goedegebuure IW, Polman M, et al. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization. J Clin Virol 2005; 32 : 7–18. 15572000
10. van der Beek MT, Laheij AM, Raber-Durlacher JE, von dem Borne PA, Wolterbeek R, et al. Viral loads and antiviral resistance of herpesviruses and oral ulcerations in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2012; 47 : 1222–1228. doi: 10.1038/bmt.2012.2 22327137
11. Frobert E, Burrel S, Ducastelle-Lepretre S, Billaud G, Ader F, et al. Resistance of herpes simplex viruses to acyclovir: An update from a ten-year survey in France. Antiviral Research 2014; 111 : 36–41. doi: 10.1016/j.antiviral.2014.08.013 25218782
12. Duan R, de Vries RD, van Dun JM, van Loenen FB, Osterhaus ADME, et al. Acyclovir Susceptibility and Genetic Characteristics of Sequential Herpes Simplex Virus Type 1 Corneal Isolates from Patients with Recurrent Herpetic Keratitis. Journal of Infectious Diseases 2009; 200 : 1402–1414. doi: 10.1086/606028 19795980
13. van Velzen M, van de Vijver DAMC, van Loenen FB, Osterhaus ADME, Remeijer L, et al. Acyclovir Prophylaxis Predisposes to Antiviral-Resistant Recurrent Herpetic Keratitis. Journal of Infectious Diseases 2013; 208 : 1359–1365. doi: 10.1093/infdis/jit350 23901090
14. Cantin E, Tanamachi B, Openshaw H. Role for gamma interferon in control of herpes simplex virus type 1 reactivation. J Virol 1999; 73 : 3418–3423. 10074196
15. Sawtell NM, Thompson RL. Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia. J Virol 1992; 66 : 2150–2156. 1312625
16. Liu T, Tang Q, Hendricks RL. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J Virol 1996; 70 : 264–271. 8523535
17. van Lint AL, Kleinert L, Clarke SRM, Stock A, Heath WR, et al. Latent Infection with Herpes Simplex Virus Is Associated with Ongoing CD8+ T-Cell Stimulation by Parenchymal Cells within Sensory Ganglia. J Virol 2005; 79 : 14843–14851. 16282484
18. Lekstrom-Himes JA, LeBlanc RA, Pesnicak L, Godleski M, Straus SE. Gamma interferon impedes the establishment of herpes simplex virus type 1 latent infection but has No impact on its maintenance or reactivation in mice [In Process Citation]. J Virol 2000; 74 : 6680–6683. 10864685
19. Tan IL, McArthur JC, Venkatesan A, Nath A. Atypical manifestations and poor outcome of herpes simplex encephalitis in the immunocompromised. Neurology 2012; 79 : 2125–2132. doi: 10.1212/WNL.0b013e3182752ceb 23136265
20. Webre JM, Hill JM, Nolan NM, Clement C, McFerrin HE, et al.Rabbit and Mouse Models of HSV-1 Latency, Reactivation, and Recurrent Eye Diseases. Journal of Biomedicine and Biotechnology 2012; 2012 : 18.
21. Schiff D, Rosenblum MK. Herpes simplex encephalitis (HSE) and the immunocompromised: a clinical and autopsy study of HSE in the settings of cancer and human immunodeficiency virus-type 1 infection [see comments]. Human Pathology 1998; 29 : 215–222. 9496822
22. Lundberg P, Ramakrishna C, Brown J, Tyszka JM, Hamamura M, et al. The Immune Response to Herpes Simplex Virus Type 1 Infection in Susceptible Mice is a Major Cause of CNS Pathology Resulting in Fatal Encephalitis. J Virol 2008; 82 : 7078–7088. doi: 10.1128/JVI.00619-08 18480436
23. Jordan SC, Toyoda M, Vo AA. Intravenous Immunoglobulin a Natural Regulator of Immunity and Inflammation. Transplantation 2009; 88 : 1–6. doi: 10.1097/TP.0b013e3181a9e89a 19584672
24. Imbach P, Lazarus AH, Khne T. Intravenous immunoglobulins induce potentially synergistic immunomodulations in autoimmune disorders. Vox Sanguinis 2010; 98 : 385–394. doi: 10.1111/j.1423-0410.2009.01264.x 19821958
25. Ferrara G, Zumla A, Maeurer M. Intravenous Immunoglobulin (IVIg) for Refractory and Difficult-to-treat Infections. The American Journal of Medicine 2012; 125 : 1036.e1031–1036.e1038. doi: 10.1016/j.amjmed.2012.01.023 22608788
26. Keller MA, Stiehm ER. Passive immunity in prevention and treatment of infectious diseases. Clin Microbiol Rev 2000; 13 : 602–614. 11023960
27. Ramakrishna C, Newo ANS, Shen Y - W, Cantin E. Passively Administered Pooled Human Immunoglobulins Exert IL-10 Dependent Anti-Inflammatory Effects that Protect against Fatal HSV Encephalitis. PLoS Pathog 2011; 7: e1002071. doi: 10.1371/journal.ppat.1002071 21655109
28. Zerboni L, Che X, Reichelt M, Qiao Y, Gu H, et al. Herpes Simplex Virus 1 Tropism for Human Sensory Ganglion Neurons in the Severe Combined Immunodeficiency Mouse Model of Neuropathogenesis. Journal of Virology 2013; 87 : 2791–2802. doi: 10.1128/JVI.01375-12 23269807
29. Lundberg P, Openshaw H, Wang M, Yang HJ, Cantin E. Effects of CXCR3 Signaling on Development of Fatal Encephalitis and Corneal and Periocular Skin Disease in HSV-Infected Mice Are Mouse-Strain Dependent. Invest Ophthalmol Vis Sci 2007; 48 : 4162–4170. 17724202
30. Yao H-W, Ling P, Tung Y-Y, Hsu S-M, Chen S-H. In Vivo Reactivation of Latent Herpes Simplex Virus 1 in Mice Can Occur in the Brain before in the Trigeminal Ganglion. Journal of Virology. 2014; 88(19):11264–70 doi: 10.1128/JVI.01616-14 25031345
31. Feldman LT, Ellison AR, Voytek CC, Yang L, Krause P, et al. Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. PNAS. 2002; 99(2):978–83 11773630
32. Ma JZ, Russell TA, Spelman T, Carbone FR, Tscharke DC. Lytic Gene Expression Is Frequent in HSV-1 Latent Infection and Correlates with the Engagement of a Cell-Intrinsic Transcriptional Response. PLoS Pathog 2014; 10: e1004237. doi: 10.1371/journal.ppat.1004237 25058429
33. Margolis TP, Elfman FL, Leib D, Pakpour N, Apakupakul K, et al. Spontaneous Reactivation of Herpes Simplex Virus Type 1 in Latently Infected Murine Sensory Ganglia. J Virol 2007; 81 : 11069–11074. 17686862
34. Krawczyk A, Arndt MAE, Grosse-Hovest L, Weichert W, Giebel B, et al. Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody. Proceedings of the National Academy of Sciences. 2013; 110(17):6760–5 doi: 10.1073/pnas.1220019110 23569258
35. Koyuncu OO, Hogue IB, Enquist LW. Virus Infections in the Nervous System. Cell Host & Microbe 2013; 13 : 379–393.
36. Frenzel K, Ganepola S, Michel D, Thiel E, Krüger D, et al. Antiviral function and efficacy of polyvalent immunoglobulin products against CMV isolates in different human cell lines. Medical Microbiology and Immunology. 2012; 201(3):277–86 doi: 10.1007/s00430-012-0229-2 22297735
37. Pavan PR, Ennis FA. The Elimination of Herpes Simplex Plaques by Antibody and the Emergence of Resistant Strains. The Journal of Immunology 1977; 118 : 2167–2175. 193992
38. Oakes JE, Lausch RN. Monoclonal antibodies suppress replication of herpes simplex virus type 1 in trigeminal ganglia. J Virol 1984; 51 : 656–661. 6088790
39. Sawtell NM. Comprehensive quantification of herpes simplex virus latency at the single-cell level. J Virol 1997; 71 : 5423–5431. 9188614
40. Sawtell NM. The Probability of In Vivo Reactivation of Herpes Simplex Virus Type 1 Increases with the Number of Latently Infected Neurons in the Ganglia. Journal of Virology 1998; 72 : 6888–6892. 9658140
41. Hoshino Y, Qin J, Follmann D, Cohen JI, Straus SE. The number of herpes simplex virus-infected neurons and the number of viral genome copies per neuron correlate with the latent viral load in ganglia. Virology 2008; 372 : 56–63. 18045638
42. Ellison AR, Yang L, Voytek C, Margolis TP. Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains. Virology 2000; 268 : 17–28. 10683323
43. Chakraborty S, Nazmi A, Dutta K, Basu A. Neurons under viral attack: Victims or warriors? Neurochemistry International 2010; 56 : 727–735. doi: 10.1016/j.neuint.2010.02.016 20206655
44. Sahin U, Ferhi O, Jeanne M, Benhenda S, Berthier C, et al. Oxidative stress–induced assembly of PML nuclear bodies controls sumoylation of partner proteins. The Journal of Cell Biology 2014; 204 : 931–945. doi: 10.1083/jcb.201305148 24637324
45. Cho H, Proll SC, Szretter KJ, Katze MG, Gale M, et al. Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positive-stranded RNA viruses. Nature Medicine. 2013; 19(4):458–64 doi: 10.1038/nm.3108 23455712
46. Margolis TP, Imai Y, Yang L, Vallas V, Krause PR. Herpes Simplex Virus Type 2 (HSV-2) Establishes Latent Infection in a Different Population of Ganglionic Neurons than HSV-1: Role of Latency-Associated Transcripts. J Virol 2007; 81 : 1872–1878. 17151134
47. Bertke AS, Ma A, Margolis MS, Margolis TP. Different Mechanisms Regulate Productive Herpes Simplex Virus 1 (HSV-1) and HSV-2 Infections in Adult Trigeminal Neurons. Journal of Virology 2013; 87 : 6512–6516. doi: 10.1128/JVI.00383-13 23514893
48. Boutell C, Everett RD. Regulation of alphaherpesvirus infections by the ICP0 family of proteins. Journal of General Virology 2013; 94 : 465–481. doi: 10.1099/vir.0.048900-0 23239572
49. Randow F, MacMicking JD, James LC. Cellular Self-Defense: How Cell-Autonomous Immunity Protects Against Pathogens. Science 2013; 340 : 701–706. doi: 10.1126/science.1233028 23661752
50. Lafaille FG, Pessach IM, Zhang S-Y, Ciancanelli MJ, Herman M, et al. Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature 2012; 491 : 769–773. doi: 10.1038/nature11583 23103873
51. van Lint A, Ayers M, Brooks AG, Coles RM, Heath WR, et al. Herpes Simplex Virus-Specific CD8+ T Cells Can Clear Established Lytic Infections from Skin and Nerves and Can Partially Limit the Early Spread of Virus after Cutaneous Inoculation. J Immunol 2004; 172 : 392–397. 14688347
52. Lang A, Nikolich-Zugich J. Development and Migration of Protective CD8+ T Cells into the Nervous System following Ocular Herpes Simplex Virus-1 Infection. J Immunol 2005; 174 : 2919–2925. 15728503
53. Orr MT, Mathis MA, Lagunoff M, Sacks JA, Wilson CB. CD8 T Cell Control of HSV Reactivation from Latency Is Abrogated by Viral Inhibition of MHC Class I. Cell Host & Microbe 2007; 2 : 172–180.
54. Jugovic P, Hill AM, Tomazin R, Ploegh H, Johnson DC. Inhibition of major histocompatibility complex class I antigen presentation in pig and primate cells by herpes simplex virus type 1 and 2 ICP47. J Virol 1998; 72 : 5076–5084. 9573278
55. Knickelbein JE, Khanna KM, Yee MB, Baty CJ, Kinchington PR, et al. Noncytotoxic Lytic Granule-Mediated CD8+ T Cell Inhibition of HSV-1 Reactivation from Neuronal Latency. Science 2008; 322 : 268–271. doi: 10.1126/science.1164164 18845757
56. Held K, Derfuss T. Control of HSV-1 latency in human trigeminal ganglia—current overview. Journal of Neurovirology 2011; 17 : 518–527. doi: 10.1007/s13365-011-0063-0 22139603
57. St. Leger A, Hendricks R. CD8+ T cells patrol HSV-1-infected trigeminal ganglia and prevent viral reactivation. Journal of Neurovirology 2011; 17 : 528–534. doi: 10.1007/s13365-011-0062-1 22161682
58. Himmelein S, St Leger A, Knickelbein J, Rowe A, Freeman M, et al. Circulating herpes simplex type 1 (HSV-1)-specific CD8+ T cells do not access HSV-1 latently infected trigeminal ganglia. Herpesviridae 2011; 2 : 5. doi: 10.1186/2042-4280-2-5 21429183
59. Gebhardt T, Wakim LM, Eidsmo L, Reading PC, Heath WR, et al. Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nat Immunol 2009; 10 : 524–530. doi: 10.1038/ni.1718 19305395
60. Wakim LM, Woodward-Davis A, Bevan MJ. Memory T cells persisting within the brain after local infection show functional adaptations to their tissue of residence. Proc Natl Acad Sci U S A 2010; 107 : 17872–17879. doi: 10.1073/pnas.1010201107 20923878
61. Egan K, Wu S, Wigdahl B, Jennings S. Immunological control of herpes simplex virus infections. Journal of NeuroVirology 2013; 19 : 328–345. doi: 10.1007/s13365-013-0189-3 23943467
62. Cantin E, Tanamachi B, Openshaw H, Mann J, Clarke K. Gamma interferon (IFN-gamma) receptor null-mutant mice are more susceptible to herpes simplex virus type 1 infection than IFN-gamma ligand null-mutant mice. J Virol 1999; 73 : 5196–5200. 10233988
63. Stock AT, Jones CM, Heath WR, Carbone FR. Rapid recruitment and activation of CD8+ T cells after herpes simplex virus type 1 skin infection. Immunol Cell Biol 2011; 89 : 143–148. doi: 10.1038/icb.2010.66 20458339
64. F Catez dr, Picard C, Held K, Gross S, Rousseau A, et al. HSV-1 Genome Subnuclear Positioning and Associations with Host-Cell PML-NBs and Centromeres Regulate LAT Locus Transcription during Latency in Neurons. PLoS Pathogens 2012; 8: e1002852. doi: 10.1371/journal.ppat.1002852 22912575
65. Catez F ric, Rousseau A, Labetoulle M, Lomonte P. Detection of the Genome and Transcripts of a Persistent DNA Virus in Neuronal Tissues by Fluorescent In situ Hybridization Combined with Immunostaining. JoVE. 2014; (83): e51091. doi: 10.3791/51091 24514006
66. Lachmann RH, Brown C, Efstathiou S. A murine RNA polymerase I promoter inserted into the herpes simplex virus type 1 genome is functional during lytic, but not latent, infection. J Gen Virol 1996; 77 (Pt 10): 2575–2582. 8887493
Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium
Článek A Phospholipase Is Involved in Disruption of the Liver Stage Parasitophorous Vacuole MembraneČlánek Host ESCRT Proteins Are Required for Bromovirus RNA Replication Compartment Assembly and FunctionČlánek Enhanced CD8 T Cell Responses through GITR-Mediated Costimulation Resolve Chronic Viral Infection
Článok vyšiel v časopisePLOS Pathogens
Najčítanejšie tento týždeň
2015 Číslo 3- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
-
Všetky články tohto čísla
- To Be or Not IIb: A Multi-Step Process for Epstein-Barr Virus Latency Establishment and Consequences for B Cell Tumorigenesis
- Is Antigenic Sin Always “Original?” Re-examining the Evidence Regarding Circulation of a Human H1 Influenza Virus Immediately Prior to the 1918 Spanish Flu
- The Great Escape: Pathogen Versus Host
- Coping with Stress and the Emergence of Multidrug Resistance in Fungi
- Catch Me If You Can: The Link between Autophagy and Viruses
- Bacterial Immune Evasion through Manipulation of Host Inhibitory Immune Signaling
- Evidence for Ubiquitin-Regulated Nuclear and Subnuclear Trafficking among Matrix Proteins
- BILBO1 Is a Scaffold Protein of the Flagellar Pocket Collar in the Pathogen
- Production of Anti-LPS IgM by B1a B Cells Depends on IL-1β and Is Protective against Lung Infection with LVS
- Virulence Regulation with Venus Flytrap Domains: Structure and Function of the Periplasmic Moiety of the Sensor-Kinase BvgS
- α-Hemolysin Counteracts the Anti-Virulence Innate Immune Response Triggered by the Rho GTPase Activating Toxin CNF1 during Bacteremia
- Induction of Interferon-Stimulated Genes by IRF3 Promotes Replication of
- Intracellular Growth Is Dependent on Tyrosine Catabolism in the Dimorphic Fungal Pathogen
- HCV Induces the Expression of Rubicon and UVRAG to Temporally Regulate the Maturation of Autophagosomes and Viral Replication
- Spatiotemporal Analysis of Hepatitis C Virus Infection
- Subgingival Microbial Communities in Leukocyte Adhesion Deficiency and Their Relationship with Local Immunopathology
- Interaction between the Type III Effector VopO and GEF-H1 Activates the RhoA-ROCK Pathway
- Attenuation of Tick-Borne Encephalitis Virus Using Large-Scale Random Codon Re-encoding
- Establishment of HSV1 Latency in Immunodeficient Mice Facilitates Efficient Reactivation
- XRN1 Stalling in the 5’ UTR of Hepatitis C Virus and Bovine Viral Diarrhea Virus Is Associated with Dysregulated Host mRNA Stability
- γδ T Cells Confer Protection against Murine Cytomegalovirus (MCMV)
- Rhadinovirus Host Entry by Co-operative Infection
- A Phospholipase Is Involved in Disruption of the Liver Stage Parasitophorous Vacuole Membrane
- Dermal Neutrophil, Macrophage and Dendritic Cell Responses to Transmitted by Fleas
- Elucidation of Sigma Factor-Associated Networks in Reveals a Modular Architecture with Limited and Function-Specific Crosstalk
- A Conserved NS3 Surface Patch Orchestrates NS2 Protease Stimulation, NS5A Hyperphosphorylation and HCV Genome Replication
- Host ESCRT Proteins Are Required for Bromovirus RNA Replication Compartment Assembly and Function
- Disruption of IL-21 Signaling Affects T Cell-B Cell Interactions and Abrogates Protective Humoral Immunity to Malaria
- Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection
- Diminished Reovirus Capsid Stability Alters Disease Pathogenesis and Littermate Transmission
- Characterization of CD8 T Cell Differentiation following SIVΔnef Vaccination by Transcription Factor Expression Profiling
- Visualization of HIV-1 Interactions with Penile and Foreskin Epithelia: Clues for Female-to-Male HIV Transmission
- Sensing Cytosolic RpsL by Macrophages Induces Lysosomal Cell Death and Termination of Bacterial Infection
- PKCη/Rdx-driven Phosphorylation of PDK1: A Novel Mechanism Promoting Cancer Cell Survival and Permissiveness for Parvovirus-induced Lysis
- Metalloprotease NleC Suppresses Host NF-κB/Inflammatory Responses by Cleaving p65 and Interfering with the p65/RPS3 Interaction
- Immune Antibodies and Helminth Products Drive CXCR2-Dependent Macrophage-Myofibroblast Crosstalk to Promote Intestinal Repair
- Adenovirus Entry From the Apical Surface of Polarized Epithelia Is Facilitated by the Host Innate Immune Response
- The RNA Template Channel of the RNA-Dependent RNA Polymerase as a Target for Development of Antiviral Therapy of Multiple Genera within a Virus Family
- Neutrophils: Between Host Defence, Immune Modulation, and Tissue Injury
- CD169-Mediated Trafficking of HIV to Plasma Membrane Invaginations in Dendritic Cells Attenuates Efficacy of Anti-gp120 Broadly Neutralizing Antibodies
- Japanese Encephalitis Virus Nonstructural Protein NS5 Interacts with Mitochondrial Trifunctional Protein and Impairs Fatty Acid β-Oxidation
- Yip1A, a Novel Host Factor for the Activation of the IRE1 Pathway of the Unfolded Protein Response during Infection
- TRIM26 Negatively Regulates Interferon-β Production and Antiviral Response through Polyubiquitination and Degradation of Nuclear IRF3
- Parallel Epigenomic and Transcriptomic Responses to Viral Infection in Honey Bees ()
- A Crystal Structure of the Dengue Virus NS5 Protein Reveals a Novel Inter-domain Interface Essential for Protein Flexibility and Virus Replication
- Enhanced CD8 T Cell Responses through GITR-Mediated Costimulation Resolve Chronic Viral Infection
- Exome and Transcriptome Sequencing of Identifies a Locus That Confers Resistance to and Alters the Immune Response
- The Role of Misshapen NCK-related kinase (MINK), a Novel Ste20 Family Kinase, in the IRES-Mediated Protein Translation of Human Enterovirus 71
- Chitin Recognition via Chitotriosidase Promotes Pathologic Type-2 Helper T Cell Responses to Cryptococcal Infection
- Activates Both IL-1β and IL-1 Receptor Antagonist to Modulate Lung Inflammation during Pneumonic Plague
- Persistence of Transmitted HIV-1 Drug Resistance Mutations Associated with Fitness Costs and Viral Genetic Backgrounds
- An 18 kDa Scaffold Protein Is Critical for Biofilm Formation
- Early Virological and Immunological Events in Asymptomatic Epstein-Barr Virus Infection in African Children
- Human CD8 T-cells Recognizing Peptides from () Presented by HLA-E Have an Unorthodox Th2-like, Multifunctional, Inhibitory Phenotype and Represent a Novel Human T-cell Subset
- Decreased HIV-Specific T-Regulatory Responses Are Associated with Effective DC-Vaccine Induced Immunity
- RSV Vaccine-Enhanced Disease Is Orchestrated by the Combined Actions of Distinct CD4 T Cell Subsets
- Concerted Activity of IgG1 Antibodies and IL-4/IL-25-Dependent Effector Cells Trap Helminth Larvae in the Tissues following Vaccination with Defined Secreted Antigens, Providing Sterile Immunity to Challenge Infection
- Structure of the Low pH Conformation of Chandipura Virus G Reveals Important Features in the Evolution of the Vesiculovirus Glycoprotein
- PPM1A Regulates Antiviral Signaling by Antagonizing TBK1-Mediated STING Phosphorylation and Aggregation
- Lipidomic Analysis Links Mycobactin Synthase K to Iron Uptake and Virulence in .
- Roles and Programming of Arabidopsis ARGONAUTE Proteins during Infection
- Impact of Infection on Host Macrophage Nuclear Physiology and Nucleopore Complex Integrity
- The Impact of Host Diet on Titer in
- Antimicrobial-Induced DNA Damage and Genomic Instability in Microbial Pathogens
- Herpesviral G Protein-Coupled Receptors Activate NFAT to Induce Tumor Formation via Inhibiting the SERCA Calcium ATPase
- The Causes and Consequences of Changes in Virulence following Pathogen Host Shifts
- Small GTPase Rab21 Mediates Fibronectin Induced Actin Reorganization in : Implications in Pathogen Invasion
- Positive Role of Promyelocytic Leukemia Protein in Type I Interferon Response and Its Regulation by Human Cytomegalovirus
- NEDDylation Is Essential for Kaposi’s Sarcoma-Associated Herpesvirus Latency and Lytic Reactivation and Represents a Novel Anti-KSHV Target
- β-HPV 5 and 8 E6 Disrupt Homology Dependent Double Strand Break Repair by Attenuating BRCA1 and BRCA2 Expression and Foci Formation
- An O Antigen Capsule Modulates Bacterial Pathogenesis in
- Variable Processing and Cross-presentation of HIV by Dendritic Cells and Macrophages Shapes CTL Immunodominance and Immune Escape
- Probing the Metabolic Network in Bloodstream-Form Using Untargeted Metabolomics with Stable Isotope Labelled Glucose
- Adhesive Fiber Stratification in Uropathogenic Biofilms Unveils Oxygen-Mediated Control of Type 1 Pili
- Vaccinia Virus Protein Complex F12/E2 Interacts with Kinesin Light Chain Isoform 2 to Engage the Kinesin-1 Motor Complex
- Modulates Host Macrophage Mitochondrial Metabolism by Hijacking the SIRT1-AMPK Axis
- Human T-Cell Leukemia Virus Type 1 (HTLV-1) Tax Requires CADM1/TSLC1 for Inactivation of the NF-κB Inhibitor A20 and Constitutive NF-κB Signaling
- Suppression of RNAi by dsRNA-Degrading RNaseIII Enzymes of Viruses in Animals and Plants
- Spatiotemporal Regulation of a T4SS Substrate by the Metaeffector SidJ
- Antigenic Properties of the Human Immunodeficiency Virus Envelope Glycoprotein Gp120 on Virions Bound to Target Cells
- Dependence of Intracellular and Exosomal microRNAs on Viral Oncogene Expression in HPV-positive Tumor Cells
- Identification of a Peptide-Pheromone that Enhances Escape from Host Cell Vacuoles
- Impaired Systemic Tetrahydrobiopterin Bioavailability and Increased Dihydrobiopterin in Adult Falciparum Malaria: Association with Disease Severity, Impaired Microvascular Function and Increased Endothelial Activation
- Transgenic Expression of the Dicotyledonous Pattern Recognition Receptor EFR in Rice Leads to Ligand-Dependent Activation of Defense Responses
- Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer
- Low Doses of Imatinib Induce Myelopoiesis and Enhance Host Anti-microbial Immunity
- Impaired Systemic Tetrahydrobiopterin Bioavailability and Increased Oxidized Biopterins in Pediatric Falciparum Malaria: Association with Disease Severity
- PLOS Pathogens
- Archív čísel
- Aktuálne číslo
- Informácie o časopise
Najčítanejšie v tomto čísle- Bacterial Immune Evasion through Manipulation of Host Inhibitory Immune Signaling
- BILBO1 Is a Scaffold Protein of the Flagellar Pocket Collar in the Pathogen
- Antimicrobial-Induced DNA Damage and Genomic Instability in Microbial Pathogens
- Attenuation of Tick-Borne Encephalitis Virus Using Large-Scale Random Codon Re-encoding
Prihlásenie#ADS_BOTTOM_SCRIPTS#Zabudnuté hesloZadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.
- Časopisy